Eileen Tanghal is a trailblazing Filipina-American engineer, entrepreneur, and venture capitalist with a rich history in the tech industry. Beginning her career as a device physicist at a successful early-stage semiconductor company, she quickly made her mark in the field. Her journey includes pivotal roles, notably leading venture capital groups at Applied Materials and ARM, and serving as a Senior Partner then Managing Director at In-Q-Tel in London, where she directed investments in significant tech startups such as Cerebras and Mythic.
In 2022, Eileen co-founded Black Opal Ventures with Dr. Tara Bishop, targeting the intersection of hard tech and healthcare innovation with a $62M fund. Beyond her VC activities, Eileen is deeply involved in education and empowerment, operating theCoderSchool Fremont with her husband and serving on the board of Notre Dame High School in San Jose, CA. Her commitment extends to promoting women's presence in STEM and venture capital, demonstrating her passion for both technological advancement and inclusivity.

One of the UK’s first Clinical Research Fellows in Digital Health with clinical training in Cardiology and Internal Medicine (ST5). Mihir works with a team of clinicians, data scientists, engineers, policymakers and patients to address patient and health system priorities. Extensive collaborations with early stage ventures and big tech, operating at the intersection of clinical AI and MedTech innovation and regulation, commercial considerations, pathway development and generation of real-world clinical and health economic evidence to implement scalable, better and more cost-effective care.

Chloe is Investor Relationships Manager of CPI Enterprises, based in London to expand the deep tech investor community, and to engage with academia and SMEs to explore potential investment and partnership opportunities.
Prior to joining CPI, Chloe has 9 years significant experience of the early-stage investment ecosystem. She was partner at China's first and largest Entrepreneurship educational platform and incubator before co-founding a US-China-based micro-VC and accelerator, which she later exited successfully. She then launched the UK entity of a family office and CVC, G5 Capital before joining CPI in 2022. Chloe started her career in media and consulting. She holds an MBA from Imperial College Business School and a MSc in Financial Journalism from City University London.

Originally qualified as a Chartered Accountant with PricewaterhouseCoopers, where she advised health and social care clients such as GSK, Roche and Aventis; Anna has previously held number of senior NHS regional commercial and improvement roles, including Commercial Programme Director at the London Commercial Support Unit.
Anna joined HIN in 2013, and since then her focus has been on building relationships between the NHS and industry. A founder of DigitalHealth.London, she also developed the DigitalHealth.London Accelerator Programme.

Patrik is a clinician scientist with a research portfolio focused in digital health implementation science. He is an NHS doctor in Acute Internal Medicine and Venture Partner supporting the first NHS-backed VC fund.
Patrik was previously the UK’s first clinical research fellow in Digital Health, completing a PhD supervised by Professor Nicholas Peters through funding from Imperial Health Charity and NIHR. He completed his academic foundation training (laboratory sciences) at University College London; award-winning MSc research at Barts and The London School of Medicine; and Core Medical Training at King’s College Hospital. He was subsequently the recipient of a prestigious Harvard Knox Fellowship, the preeminent scholarship for UK citizens pursuing postgraduate study at Harvard University. He completed his Masters in Public Health (MPH, health policy and digital health concentration) while cross-registered at the Massachusetts Institute for Technology (MIT), Kennedy School of Government, and Harvard Medical and Business Schools. HIs practicum was supervised by Dr. Trishan Panch at Wellframe, which provides digital health management to tens of millions of patients in the US.

Krishan Ramdoo is the CEO and Founder of Tympahealth technologies. He has developed the world’s first all-in-one ear and hearing health assessment system. It brings together three different diagnostic and treatment systems into one. It combines a digital otoscope, microsuction wax removal and a hearing screener into a single, hand-held, portable device delivered by trained allied health professionals.Dr. Ramdoo started his Medical career in 2009 and after initially working in the Oxford University hospitals he went on to be an Ear, Nose and Throat surgeon in London before embarking on his PhD at UCL, where his area of interest became the impact of hearing loss globally.
In 2023, TympaHealth raised $23M in Series A funding led by Octopus Ventures.

James is the co-founder of SomX, an agency specializing in health tech communications. He edits the engaging Healthtech Pigeon newsletter and podcast and hosts The Healthtech Podcast with an international audience. A contributor for Forbes, James covers health tech, startups, and innovation. His healthcare background spans working in anesthetics and ICU, policy involvement with NHS England, and leading the DigitalHealth.London Accelerator. He founded HS. Ventures to invest in deep tech and holds degrees in medicine, biomedical sciences, and education, also lecturing globally on health tech entrepreneurship.

Jessica is co-founder & CXO of SomX, a healthtech and biotech-specific communications group. She is also an executive editor and regular host for Healthtech Pigeon, a news brand rounding up the sector's news. Previously an Associate Director at global agency, FleishmanHillard, Jessica has extensive experience across the healthcare ecosystem from the NHS, industry, Royal Colleges and charities, as well as in consumer health, healthtech, medical devices and pharmaceuticals. She specialises in building and leading teams to design and deliver purpose-driven, integrated and targeted communications strategies that support companies on a mission to solve healthcare's biggest challenges.

Francisco is the CEO and founder of Bowhead health, a digital health platform which aims to empower people to own and control their health data. It enables users to safely and easily share self-reported health behaviours and symptom survey data with researchers. He previously founded Revenue.com, a native advertising technology, as well as Titan Gaming (acquired, now Playsino) with over 14 million users in his dorm room at McGill University. Titan launched the first fully automated cash tournament system for online games in 2008. He is a Forbes 30 under 30 recipient.

Christian is co-head of private credit at Blackrock. He founded DiaMonTech, an award-winning medical technology start-up pioneering non-invasive blood glucose measurements. In 2022, they completed a $5 million investment round, bringing its total funding to over $20 million. Samsung Ventures is also one of its strategic partners. DiaMonTech’s goal is to globally provide people living with diabetes with a ground-breaking technology for managing blood glucose levels without finger pricking, needles and test strips. The patented mid-infrared technology enables non-invasive blood glucose measurement using a pain-free laser-based detection that is as easy to use as the fingerprint sensor on a smartphone. He holds an MBA from LBS.